NK-1 Receptor Antagonists and Pruritus: Review of Current Literature
Abstract The discovery of the first neurokinin 1 (NK-1) receptor antagonist was a turning point in the prevention of chemotherapy-induced nausea and vomiting. The NK-1 antagonists are a novel class of drugs that possess antidepressant, anxiolytic, and antiemetic properties. Recently, clinicians have...
Saved in:
Main Authors: | Marcelina Pojawa-Gołąb (Author), Kamila Jaworecka (Author), Adam Reich (Author) |
---|---|
Format: | Book |
Published: |
Adis, Springer Healthcare,
2019-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Skin Pain in Patients with Atopic Dermatitis or Psoriasis: A Web-based Survey
by: Marcelina Pojawa-Gołąb, et al.
Published: (2020) -
Slowly Progressing Asymptomatic Disseminated Telangiectasias: A Quiz
by: Justyna Szczęch, et al.
Published: (2018) -
Casopitant: a novel NK1-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting
by: Christina Ruhlmann, et al.
Published: (2009) -
Simulation of the oxidative metabolization pattern of netupitant, an NK1 receptor antagonist, by electrochemistry coupled to mass spectrometry
by: Ruxandra Chira, et al.
Published: (2021) -
Mediators of Pruritus in Psoriasis
by: Adam Reich, et al.
Published: (2007)